Brief: Innovative Pharmaceutical Biotech Posts H1 Revenue Of HKD3 Mln
29/11/2024 13:57
Nov 29 (Reuters) - Innovative Pharmaceutical Biotech H1 net income attributable HKD 101.7 million. * H1 revenue HKD 3 million
Recent news on Starcoin
See all newsBrief: Starcoin Group Says Trading In Shares Of Co Will Suspend From 6 May
Brief: Starcoin Enters Non-Binding Memorandum Of Understanding With Marvel Nice
Brief: Starcoin Group Enters MoU For Strategic Cooperation With Huamei Haibo Biotechnology (Chongqing)
Brief: Starcoin Group Says Unit, Others Enters Deal For Brazilian Gold Mine RWA Tokenization
Brief: Starcoin Group, Newbridge And Conflux Foundation Entered MoU